Arkolith/Insider Trading/LXRX

LXRX Insider Trading

Lexicon Pharmaceuticals, Inc. · full profile →Last filing Jun 3, 2026
Net Buying · 180d
Open-Market Buys (180d)
$2.7M
2 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$2.7M
open market, 180d
Reporting Insiders
2
8 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jun 3, 2026Debbane RaymondDirectorOption exercise(M)89K—$0
Jun 3, 2026Debbane RaymondDirectorOption exercise(M)89K—$0
Jun 3, 2026Amouyal PhilippeDirectorOption exercise(M)89K—$0
Jun 3, 2026Amouyal PhilippeDirectorOption exercise(M)89K—$0
Jun 3, 2026Cheung IvanDirectorOption exercise(M)89K—$0
Jun 3, 2026Cheung IvanDirectorOption exercise(M)89K—$0
Jun 3, 2026Barker Sam LDirectorOption exercise(M)89K—$0
Jun 3, 2026Barker Sam LDirectorOption exercise(M)89K—$0
Jun 3, 2026Sullivan Diane E.DirectorOption exercise(M)89K—$0
Jun 3, 2026Sullivan Diane E.DirectorOption exercise(M)89K—$0
Jun 3, 2026Sobecki Christopher JDirectorOption exercise(M)89K—$0
Jun 3, 2026Sobecki Christopher JDirectorOption exercise(M)89K—$0
Jun 3, 2026Swain Judith LDirectorOption exercise(M)89K—$0
Jun 3, 2026Swain Judith LDirectorOption exercise(M)89K—$0
May 1, 2026Sobecki Christopher JDirectorGrant(A)43K—$0
May 1, 2026Sobecki Christopher JDirectorGrant(A)36K—$0
May 1, 2026Swain Judith LDirectorGrant(A)43K—$0
May 1, 2026Swain Judith LDirectorGrant(A)36K—$0
May 1, 2026Sullivan Diane E.DirectorGrant(A)43K—$0
May 1, 2026Sullivan Diane E.DirectorGrant(A)36K—$0
May 1, 2026Debbane RaymondDirectorGrant(A)43K—$0
May 1, 2026Debbane RaymondDirectorGrant(A)36K—$0
May 1, 2026Cheung IvanDirectorGrant(A)43K—$0
May 1, 2026Cheung IvanDirectorGrant(A)36K—$0
May 1, 2026Barker Sam LDirectorGrant(A)43K—$0
May 1, 2026Amouyal PhilippeDirectorGrant(A)43K—$0
May 1, 2026Amouyal PhilippeDirectorGrant(A)36K—$0
May 1, 2026Barker Sam LDirectorGrant(A)36K—$0
Apr 30, 2026Artal Participations S.a r.l.Director, 10% OwnerOption exercise(M)408K—$0
Apr 30, 2026Artal Participations S.a r.l.Director, 10% OwnerGrant(A)408K——
Apr 30, 2026Artal Participations S.a r.l.Director, 10% OwnerOption exercise(M)20.4M—$0
Feb 28, 2026Exton MichaelChief Executive Officer, DirectorTax withholding(F)205K$1.47$301K
Feb 28, 2026Exton MichaelChief Executive Officer, DirectorOption exercise(M)503K——
Feb 28, 2026Exton MichaelChief Executive Officer, DirectorOption exercise(M)503K——
Feb 28, 2026Coiante Scott MSVP, Chief Financial OfficerOption exercise(M)160K——
Feb 28, 2026Coiante Scott MSVP, Chief Financial OfficerTax withholding(F)55K$1.47$81K
Feb 28, 2026Coiante Scott MSVP, Chief Financial OfficerOption exercise(M)160K——
Feb 28, 2026Crum Brian TSVP, General Counsel & Secr.Option exercise(M)170K——
Feb 28, 2026Crum Brian TSVP, General Counsel & Secr.Option exercise(M)33K——
Feb 28, 2026Crum Brian TSVP, General Counsel & Secr.Tax withholding(F)105K$1.47$154K
Feb 28, 2026Crum Brian TSVP, General Counsel & Secr.Option exercise(M)69K——
Feb 28, 2026Crum Brian TSVP, General Counsel & Secr.Option exercise(M)170K——
Feb 28, 2026Crum Brian TSVP, General Counsel & Secr.Option exercise(M)69K——
Feb 28, 2026Crum Brian TSVP, General Counsel & Secr.Option exercise(M)33K——
Feb 28, 2026DeFrancesco LisaSVP, IR and Corp CommTax withholding(F)75K$1.47$110K
Feb 28, 2026DeFrancesco LisaSVP, IR and Corp CommOption exercise(M)128K——
Feb 28, 2026DeFrancesco LisaSVP, IR and Corp CommOption exercise(M)25K——
Feb 28, 2026DeFrancesco LisaSVP, IR and Corp CommOption exercise(M)25K——
Feb 28, 2026DeFrancesco LisaSVP, IR and Corp CommOption exercise(M)128K——
Feb 28, 2026Gopinathan SumaSVP, DiscoveryOption exercise(M)66K——
Feb 28, 2026Gopinathan SumaSVP, DiscoveryTax withholding(F)24K$1.47$36K
Feb 28, 2026Gopinathan SumaSVP, DiscoveryOption exercise(M)20K——
Feb 28, 2026Gopinathan SumaSVP, DiscoveryOption exercise(M)14K——
Feb 28, 2026Gopinathan SumaSVP, DiscoveryOption exercise(M)14K——
Feb 28, 2026Gopinathan SumaSVP, DiscoveryOption exercise(M)20K——
Feb 28, 2026Gopinathan SumaSVP, DiscoveryOption exercise(M)66K——
Feb 28, 2026Granowitz Craig BSVP, Chief Medical OfficerOption exercise(M)36K——
Feb 28, 2026Granowitz Craig BSVP, Chief Medical OfficerOption exercise(M)74K——
Feb 28, 2026Granowitz Craig BSVP, Chief Medical OfficerTax withholding(F)109K$1.47$160K
Feb 28, 2026Granowitz Craig BSVP, Chief Medical OfficerOption exercise(M)202K——
Feb 28, 2026Granowitz Craig BSVP, Chief Medical OfficerOption exercise(M)74K——
Feb 28, 2026Granowitz Craig BSVP, Chief Medical OfficerOption exercise(M)36K——
Feb 28, 2026Granowitz Craig BSVP, Chief Medical OfficerOption exercise(M)202K——
Feb 28, 2026Martens Rachel YapSVP, Partnerships & Corp StratTax withholding(F)36K$1.47$53K
Feb 28, 2026Martens Rachel YapSVP, Partnerships & Corp StratOption exercise(M)67K——
Feb 28, 2026Martens Rachel YapSVP, Partnerships & Corp StratOption exercise(M)67K——
Feb 28, 2026McDermott WendySVP, Human ResourcesOption exercise(M)52K——
Feb 28, 2026McDermott WendySVP, Human ResourcesOption exercise(M)28K——
Feb 28, 2026McDermott WendySVP, Human ResourcesOption exercise(M)144K——
Feb 28, 2026McDermott WendySVP, Human ResourcesTax withholding(F)68K$1.47$100K
Feb 28, 2026McDermott WendySVP, Human ResourcesOption exercise(M)52K——
Feb 28, 2026McDermott WendySVP, Human ResourcesOption exercise(M)144K——
Feb 28, 2026McDermott WendySVP, Human ResourcesOption exercise(M)28K——
Feb 25, 2026Debbane RaymondDirectorBuy(P)2K$1.49$3K
Feb 23, 2026Debbane RaymondDirectorBuy(P)100K$1.47$147K
Feb 20, 2026Debbane RaymondDirectorBuy(P)100K$1.48$148K
Feb 19, 2026Debbane RaymondDirectorBuy(P)50K$1.44$72K
Feb 18, 2026Debbane RaymondDirectorBuy(P)134K$1.32$176K
Feb 17, 2026Debbane RaymondDirectorBuy(P)77K$1.31$101K
Feb 17, 2026Artal International S.C.A.Director, 10% OwnerGrant(A)41K$65.00$2.7M
Feb 13, 2026Debbane RaymondDirectorBuy(P)58K$1.31$76K
Feb 12, 2026Exton MichaelChief Executive Officer, DirectorGrant(A)862K—$0
Feb 12, 2026Exton MichaelChief Executive Officer, DirectorGrant(A)1.3M—$0
Feb 12, 2026Coiante Scott MSVP, Chief Financial OfficerGrant(A)409K—$0
Feb 12, 2026Coiante Scott MSVP, Chief Financial OfficerGrant(A)273K—$0
Feb 12, 2026Crum Brian TSVP, General Counsel & Secr.Grant(A)450K—$0
Feb 12, 2026Crum Brian TSVP, General Counsel & Secr.Grant(A)300K—$0
Feb 12, 2026DeFrancesco LisaSVP, IR and Corp CommGrant(A)258K—$0
Feb 12, 2026DeFrancesco LisaSVP, IR and Corp CommGrant(A)386K—$0
Feb 12, 2026Gopinathan SumaSVP, DiscoveryGrant(A)358K—$0
Feb 12, 2026Gopinathan SumaSVP, DiscoveryGrant(A)238K—$0
Feb 12, 2026Granowitz Craig BSVP, Chief Medical OfficerGrant(A)347K—$0
Feb 12, 2026Granowitz Craig BSVP, Chief Medical OfficerGrant(A)520K—$0
Feb 12, 2026Martens Rachel YapSVP, Partnerships & Corp StratGrant(A)291K—$0
Feb 12, 2026Martens Rachel YapSVP, Partnerships & Corp StratGrant(A)194K—$0
Feb 12, 2026McDermott WendySVP, Human ResourcesGrant(A)375K—$0
Feb 12, 2026McDermott WendySVP, Human ResourcesGrant(A)250K—$0
Feb 2, 2026Artal Group S.A.Director, 10% OwnerBuy(P)1.5M$1.30$2.0M
Feb 2, 2026Artal Group S.A.Director, 10% OwnerGrant(A)3.8M$1.30$5.0M
Feb 2, 2026Artal Group S.A.Director, 10% OwnerGrant(A)18.6M$1.30$24.1M

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-20. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).